76 related articles for article (PubMed ID: 3260898)
1. Regulation of murine plasmacytoma transferrin receptor expression and G1 traversal by plasmacytoma cell growth factor.
Neckers LM; Nordan RP
J Cell Physiol; 1988 Jun; 135(3):495-501. PubMed ID: 3260898
[TBL] [Abstract][Full Text] [Related]
2. The role of plasmacytoma growth factor in the in vitro responses of murine plasmacytoma cells.
Nordan RP; Mock BA; Neckers LM; Rudikoff S
Ann N Y Acad Sci; 1989; 557():200-5. PubMed ID: 2786694
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line.
Le J; Reis LF; Vilcek J
Lymphokine Res; 1988; 7(2):99-106. PubMed ID: 3261383
[TBL] [Abstract][Full Text] [Related]
4. Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1.
Nordan RP; Pumphrey JG; Rudikoff S
J Immunol; 1987 Aug; 139(3):813-7. PubMed ID: 3496392
[TBL] [Abstract][Full Text] [Related]
5. Suppression of programmed death and G1 arrest in B-cell hybridomas by interleukin-6 is not accompanied by altered expression of immediate early response genes.
Sabourin LA; Hawley RG
J Cell Physiol; 1990 Dec; 145(3):564-74. PubMed ID: 1703172
[TBL] [Abstract][Full Text] [Related]
6. Antiviral action of tumor necrosis factor in human fibroblasts is not mediated by B cell stimulatory factor 2/IFN-beta 2, and is inhibited by specific antibodies to IFN-beta.
Reis LF; Le JM; Hirano T; Kishimoto T; Vilcek J
J Immunol; 1988 Mar; 140(5):1566-70. PubMed ID: 3279118
[TBL] [Abstract][Full Text] [Related]
7. Continuous cytotoxic T cell lines reactive against murine plasmacytoma tumor-associated antigens.
Giorgi JV; Warner NL
J Immunol; 1981 Jan; 126(1):322-30. PubMed ID: 6161166
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoma growth factor activity of murine granulocyte-macrophage colony-stimulating factor.
Vink A; Vandenabeele P; Uyttenhove C; Cayphas S; Van Snick J
J Immunol; 1988 Sep; 141(6):1996-9. PubMed ID: 3049799
[TBL] [Abstract][Full Text] [Related]
9. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
Lasky JL; Ponzio NM; Thorbecke GJ
J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
[TBL] [Abstract][Full Text] [Related]
10. The role of the transferrin receptor in human B lymphocyte activation.
Neckers LM; Yenokida G; James SP
J Immunol; 1984 Nov; 133(5):2437-41. PubMed ID: 6090534
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cell cycle entry and G1 progression by CSF-1.
Roussel MF
Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
[TBL] [Abstract][Full Text] [Related]
12. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.
Castagnola J; MacLeod C; Sunada H; Mendelsohn J; Taetle R
J Cell Physiol; 1987 Sep; 132(3):492-500. PubMed ID: 3498729
[TBL] [Abstract][Full Text] [Related]
13. Growth factor receptor expression during in vitro differentiation of partially purified populations containing murine stem cells.
Ashihara E; Vannucchi AM; Migliaccio G; Migliaccio AR
J Cell Physiol; 1997 Jun; 171(3):343-56. PubMed ID: 9180904
[TBL] [Abstract][Full Text] [Related]
14. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
[TBL] [Abstract][Full Text] [Related]
16. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
Dolnikov A; Millington M; Sun LQ; Symonds G
Cancer Gene Ther; 2000 Nov; 7(11):1491-503. PubMed ID: 11129291
[TBL] [Abstract][Full Text] [Related]
17. Control of B cell proliferation: arrest of B cells in late G1 underlies immunosuppression induced by plasma cell tumors.
Berman JE; Zolla-Pazner S
J Immunol; 1987 May; 138(9):2805-12. PubMed ID: 3494771
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of c-myc and the transferrin receptor in G1 synchronized M1 myeloid leukemia cells.
Neckers LM; Tsuda H; Weiss E; Pluznik DH
J Cell Physiol; 1988 May; 135(2):339-44. PubMed ID: 3372600
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
[TBL] [Abstract][Full Text] [Related]
20. Diltiazem inhibits transferrin receptor expression and causes G1 arrest in normal and neoplastic T cells.
Neckers LM; Bauer S; McGlennen RC; Trepel JB; Rao K; Greene WC
Mol Cell Biol; 1986 Dec; 6(12):4244-50. PubMed ID: 2432398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
